Neuronetics Anti-Depression Device Not Equivalent To Shock Therapy – Panel

Neuronetics' NeuroStar transcranial magnetic stimulation system is not substantially equivalent to electroconvulsive "shock" therapy for treatment of major depressive disorder, FDA's Neurological Devices Panel concluded Jan. 26

More from Archive

More from Medtech Insight